X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

OLMA

Closed

Olema Pharmaceuticals Inc

4.37
+0.11 (+2.58%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 4.26
Day's Range: 4.1206 - 4.49
Send
When Written:
 
3.29
Olema Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that focuses on the development of targeted therapies for women's cancers. The company's lead product candidate, OP-1250, is a small molecule inhibitor of the estrogen receptor (ER) that is being evaluated in Phase 1/2 clinical trials for the treatment of patients with ER-positive, HER2-negative breast cancer. Olema Pharmaceuticals was founded in 2016 and is headquartered in San Francisco, California. The company's mission is to improve the lives of women with cancer by developing innovative therapies that target the underlying biology of their disease.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X